SCHEMBL2707609

SCHEMBL2707609

CC(C)C1C=CC(c2nn(-c3cccc(C(=O)O)c3)c(=O)s2)=CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.37
KMT2A Q03164 5/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
POLB P06746 3/20 0.35
RECQL P46063 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
APEX1 P27695 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
MEN1 O00255 4/20 0.34
ALDH1A1 P00352 4/20 0.34
GAA P10253 4/20 0.34
KDM4E B2RXH2 2/20 0.34
HSD17B10 Q99714 2/20 0.34
HPGD P15428 2/20 0.34
MAPT P10636 2/20 0.34
BLM P54132 2/20 0.34
USP2 O75604 1/20 0.34
MYC P01106 1/20 0.34
HSPA1A P0DMV8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL181810 0.75 PDE5A (0.43) L3MBTL1KMT2AIDO1TDO2POLB
SCHEMBL12171669 0.62 FAAH (0.39) L3MBTL1KMT2AIDO1TDO2POLB
SCHEMBL182540 0.61 MEN1 (0.45) KMT2APOLBMEN1MAPTTP53
SCHEMBL22349773 0.60 DHODH (0.44) L3MBTL1KMT2AIDO1TDO2POLB
SCHEMBL17177053 0.59 KMT2A (0.56) L3MBTL1KMT2APOLBRECQLTDP1
SCHEMBL31420309 0.59 GAA (0.55) L3MBTL1KMT2AIDO1TDO2POLB
SCHEMBL30474531 0.59 L3MBTL1 (0.59) L3MBTL1KMT2APOLBRECQLTDP1
SCHEMBL16554846 0.59 L3MBTL1 (0.59) L3MBTL1KMT2APOLBRECQLTDP1
SCHEMBL3011187 0.59 GAA (0.55) L3MBTL1KMT2AIDO1TDO2POLB
SCHEMBL21935952 0.59 MEN1 (0.69) L3MBTL1KMT2APOLBRECQLTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387995-A1 Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith PTC Therapeutics, Inc. (US) 2011-11-23 EP disclosed